Omeros reported $37.44M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acelrx Pharmaceuticals ACRX:US $ 14.14M 4.71M
Adma Biologics ADMA:US $ 16.94M 33.64M
Aerie Pharmaceuticals AERI:US $ 51.45M 12.03M
Alnylam Pharmaceuticals ALNY:US $ 416.5M 56.51M
Biomarin Pharmaceutical BMRN:US $ 494.65M 112.61M
Cytokinetics CYTK:US $ 99.84M 18.14M
Dynavax Technologies DVAX:US $ 128.24M 45.01M
Gilead Sciences GILD:US $ 4231M 2162M
Heron Therapeutics HRTX:US $ 77.13M 9.25M
Insmed INSM:US $ 153.54M 10.6M
Intercept Pharmaceuticals ICPT:US $ 85.12M 13.73M
Knight Therapeutics Inc GUD:CN C$ 72.93M 9.08M
Macrogenics MGNX:US $ 67.82M 9.92M
Mirati Therapeutics MRTX:US $ 182.57M 2.36M
Omeros OMER:US $ 37.44M 2.39M
Pacira Pharmaceuticals PCRX:US $ 138.18M 2.42M
Pfizer PFE:US $ 15640M 148M
Regulus Therapeutics RGLS:US $ 7.18M 606K
Rockwell Medical RMTI:US $ 23.16M 414K
Sangamo Biosciences SGMO:US $ 75.11M 1.62M
Sarepta Therapeutics SRPT:US $ 444.62M 146.91M
United Therapeutics UTHR:US $ 265.1M 89.5M
Vertex Pharmaceuticals VRTX:US $ 1089.9M 33.3M
Vital Therapies VTL:US $ 20.61M 825K
Xoma XOMA:US $ 5.75M 578K